Spectrum of Dermatologic Adverse Events Associated With Amivantamab Use

JAMA Dermatol. 2023 Jan 1;159(1):109-111. doi: 10.1001/jamadermatol.2022.4466.
No abstract available

Plain language summary

This case series describes the different dermatologic adverse events that patients experienced while using amivantamab.

MeSH terms

  • Antibodies, Bispecific*
  • Drug Eruptions* / diagnosis
  • Drug Eruptions* / epidemiology
  • Drug Eruptions* / etiology
  • Humans

Substances

  • amivantamab-vmjw
  • Antibodies, Bispecific